Eurolive Study (2002-2004)

The Eurolive Study is aimed at assessing the beneficial effects of olive oil on human health. It is focused on examining the importance of the phenolic compounds of olive oil on oxidative stress and oxidative damage in humans and aimed at providing information to the European Consumers, and to the Olive Oil Industry, about the cost/benefit ratio of the different olive oils on the market.

Olive oils with low, medium and high phenolic content were administered to 30 healthy volunteers in six European centers (Spain, Italy, Germany-Potsdam, Germany-Berlin, Denmark and Finland) in three week periods with two week washout periods between different olive oils.

EUROLIVE consortium, the health benefits of virgin and common olive oil in prevention of pathologies that affect cardiovascular function and their cost/benefit ratio. EU-funded clinical trial, PI Dr. Maria Isabel Covas, Institut Municipal d'Investigacio Medica (IMIM), Barcelona, Spain, Funded by the EU FP6 program.

More information: jaakko.mursu at uef.fi, sari.voutilainen at uef.fi.

Publications:

Anja Machowetz et al: Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. FASEB J 2007;21:45-52.

The EUROLIVE Study Group: The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial. The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial. Clinical Nutrition 2011;30:490-493.

Maribel Covas et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med 2006;145:333-41.